Search Results 91-100 of 505 for ❗베스트토토【평생베스트.com】베스트토토검증❗

  1. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    ... best. Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. Diffuse Large B Cell Lymphoma Clinical Trials - Mayo Clinic Research

    The main purpose of this study is to determine the best dose of MEDI6469 that is safe and tolerable when given as monotherapy and in combination with ...

  3. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    About this study. This phase I/II trial studies the side effects and best dose of veliparib and topotecan hydrochloride and to see how well they work in ...

  4. Niemann-Pick Disease Clinical Trials - Mayo Clinic Research

    ... best standard of care; patient's standard of care may, or may not, include miglustat. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About ...

  5. A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. cancer risk Archives - Mayo Clinic News Network

    ... A cancer recurrence happens because, despite the best efforts to help you ... The best approach to smoking is not to start. If you smoke, however ...

  7. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  8. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  10. A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System

    ... best. Study IDs. Site IRB. Scottsdale/Phoenix, Arizona: 13-006663. NCT ID: NCT01166347. Sponsor Protocol Number: HW004. About this study. The purpose of this ...